First Personal Financial Services Kala Pharmaceuticals, Inc. Transaction History

First Personal Financial Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 07, 2018	SELL	$13.3 - $17.49 $5,878 - $7,730	-442 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$12.26 - $18.98 $3,678 - $5,694	-300 Reduced 40.43%	442 $7,000
Q4 2017 Jan 25, 2018	SELL	$13.68 - $23.17 $3,214 - $5,444	-235 Reduced 24.05%	742 $14,000
Q3 2017 Nov 01, 2017	BUY	$19.86 - $26.53 $19,403 - $25,919	977	977 $22,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $10.1M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.